This analysis showed that a number of the IL-10–regulated IBD GWAS candidate genes and their associated networks are strongly down-regulated in the WT control Mφs after combined treatment compared with LPS treatment alone. This evidence concerns the gene IL10 and inflammatory bowel disease.